Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
INBRAIN Neuroelectronics Awarded €4 Million Grant from Spain’s PERTE Chip Program to Advance Graphene-Based Brain-Computer Interfaces
-
Broadridge Enhances OpsGPT®, introducing new Agentic Capabilities to Further Optimize Global Post-Trade Operations
-
AudioCodes Reports First Quarter 2025 Results
-
Memorize Quran Online with Confidence: Top-Rated Quran Memorization Classes for All Ages
-
MND SNOW launches a new generation of snowmaking solutions
-
Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy
-
Progress on share buyback programme
-
Invitation to Enefit Green investor webinars presenting Q1 2025 interim results
-
Elis: Disclosure of trading in own shares occured from April 28 to May 2, 2025
-
Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period
-
Appointment of Nominated & Financial Adviser
-
Transaction in Own Shares
-
Transactions Made Under the Share Buy-back Programme for Stolt-Nielsen Limited
-
HAFNIA LIMITED: Audited Financial Statements 2024
-
Skanska builds data center project in Western USA for USD 164M, about SEK 1.7 billion
-
Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting
-
Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation
-
Three-month interim report (Q1) 2025 (unaudited)
-
Q1 2025 INTERIM REPORT - 2025-TRANSITION PROGRESSING
-
Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25
-
International Petroleum Corporation Announces First Quarter 2025 Financial and Operational Results
-
Connected Energy and Forsee Power to Develop Grid-Scale Energy Storage Using Second Life Batteries From Electric Buses
-
Report for the three months ended 31 March 2025
-
Inbank unaudited financial results for Q1 2025
-
AngloGold Ashanti and Gold Fields Agree to Pause Proposed Ghana JV Discussions
-
Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation
-
BW Offshore: 2025 Annual General Meeting – Notice
-
Viridien secures sale of Sercel Marlin Offshore Logistics solution to ONGC
-
Metavista3D Enters into Memorandum of Understanding with VIN International to Develop 3D Camera Prototype for Vehicles
-
Metavista3D Enters into Memorandum of Understanding with VIN International to Develop 3D Camera Prototype for Vehicles
-
Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment
-
BW LPG Limited – Q1 2025 Financial Report Release and Earnings Presentation on 20 May 2025
-
Colle AI Prioritizes Solana Tool Expansion to Accelerate Creator-Centric Utility
-
Atua AI Reinforces Bitcoin Architecture for Long-Term AI Infrastructure Growth
-
Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy
-
Innate Pharma announces conference call and webcast for Q1 2025 business update
-
Azelis Reinforces Its Footprint in India With the Acquisition of S. Amit Group
-
RSA Announces New Innovations to Stop Help Desk Scams and Protect Passwordless Environments
-
Novaremed Announces Completion of Enrollment in NIH-sponsored Phase 2b Study with Non-opioid NRD.E1 for the Treatment of Chronic Pain Associated with Diabetic Peripheral Neuropathy
-
Philips delivers on Q1 results, with ongoing order intake growth
-
KH Group Plc’s Business Review January–March 2025: Moderate growth and improving profitability
-
Start of Day Message
-
Hexagon Purus ASA: Results for the first quarter 2025
-
Steady course in turbulent times
-
26/2025・Trifork Group: Interim report for the quarter ending 31 March 2025
-
Novaremed Announces Completion of Enrollment in NIH-sponsored Phase 2b Study with Non-opioid NRD.E1 for the Treatment of Chronic Pain Associated with Diabetic Peripheral Neuropathy
-
Weekly progress on share repurchase program to cover share plans and reduce capital
-
Dividend Payments Ex-date of AS Tallinna Sadam
-
Roche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity
-
argenx to Present at BofA Securities 2025 Health Care Conference


